|Articles|September 2, 2020

Pharmaceutical Technology

  • Pharmaceutical Technology-09-02-2020
  • Volume 44
  • Issue 9

Pressure Transmitter for Single-Use Applications

The Rosemount 550PT Pressure Transmitter from Emerson is designed for single-use bioprocessing applications to enhance processes while preserving product integrity.

The Rosemount 550PT Pressure Transmitter from Emerson is designed for single-use bioprocessing applications to enhance processes while preserving product integrity.

Installed with a disposable Rosemount 551 Single-Use Process Connector, the device integrates a flexible isolating diaphragm that provides a sterile barrier that keeps the pressure instrument’s sensor separate from the process media, eliminating contamination risks and making the device reusable.

The device is compact for single-use applications and comes equipped with a transmitter that generates a standard 4-20mA signal output. The pressure sensor offers +/- 0.15 psi accuracy, and after being clamped to the process connector, the transmitter can be zeroed in place for batch-to-batch repeatability and long-term stability.

The device also comes equipped with a sensor and matching process connector combination, which can be included in several applications and can withstand 75 psi with the instrument installed and 7.5 psi without an instrument installed.


Emerson


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.